You had it before. You're terrified it's happening again. Here is what you actually control.
Russell W. Raskin, MD · Board-Certified Emergency Medicine & Internal Medicine · R.W. Raskin Health Protocols, LLC
You had it before. Maybe last year, maybe longer ago than that. It laid you out for two weeks, three weeks, a month. You couldn't work. You couldn't think straight. Every cough triggered another cough. The cough finally let up. You could sleep again. But it still took a week or more before you felt like yourself.
You're not sick with bronchitis right now. You have a cold. To make matters worse, there's an underpinning of fear that bronchitis will develop again.
I have a name for that.
R.W. Raskinism
Post-Traumatic Bronchitis Disorder — PTBD.
That fear is real, and it flavors every decision you make about this cold going forward.
You may be thinking you need to call your doctor for an antibiotic, possibly because that's what you were given last time, or because that's just what you've always done when a cold like this shows up.
An antibiotic neither prevents nor treats bronchitis. It did not prevent it or treat it the last time. It will not prevent it or treat it this time. What it can do is add risk.
Here's what actually helps, and it's far simpler than you think, yet far harder to execute: giving your immune system the best possible conditions to do what it's built to do.
The biggest lever you have is supporting your immune system.
Of everything you can do to support it, rest matters most.
And that rest means essentially doing nothing, more than you'd probably choose to on your own.
This is the hardest prescription I have to write. Patients don't want to hear it. They want a pill. They want (read: need) to keep working. They want to keep moving. But no pill has been shown to help. The moment you decide you're well enough to push through is the moment you extend the arc. That's the moment a one-week cold becomes three weeks.
You cannot substitute rest with a medication you don't need. You cannot skip the actual work and expect a pill to do it for you.
So Here's the Plan.
Rest is the foundation, but it's not the whole plan. The Four Pillars give you the full framework for supporting your immune system while it does the work.
Read the full article
Raskin's Four Pillars of Immune Optimization →
But for bronchitis, one pillar dominates.
R.W. Raskinism
Absolute rest. Not rest when you feel like it. Not general rest. Absolute rest. The moment you know you're sick, you stop.
You stop work. You talk less. You stop moving more than you have to. You sleep the best you can. You give your immune system the best chance to do its job without the interference of your daily life. This is where most patients fall short. They push until they're forced to stop. By then, their arc has steepened and their cough has deepened. Rest, which was a suggestion, now becomes a necessity. Following the Four Pillars from the start is your best offense.
What You Control, What You Don't
Whether your cold becomes bronchitis depends on the specific virus you catch and how your immune system responds. You don't control that. Whether that bronchitis becomes a one-week illness or a three-week nightmare has some luck built into it too, since it depends on how your particular immune response plays out. But you likely have some influence over it, and it comes down to whether you follow the Four Pillars starting day one, or wait until you're forced to.
Rest matters most among the Four Pillars, but no single piece does it alone. Patients who follow the full protocol early seem to have better luck avoiding a rougher, longer course. Patients who push through and wait to rest seem more likely to run into it. That's not a guess. That's what I've seen over and over with my patients, myself included.
How You Know You're Turning the Corner
You'll know the arc begins its descent when the tickle that makes you feel like every cough is about to overwhelm you starts to quiet, and the thick, discolored mucus that marked the plateau starts to clear. That's your signal. That's your body telling you you're on the road to recovery.
The Prescription
If it isn't already clear, antibiotics and other medications do not help garden variety bronchitis. A plan is the only thing we have that can help. Follow it and you give yourself the best chance at a shorter, easier course.
You need permission to stop. You need to understand that rest isn't weakness. It's the intervention. Time and your immune system are the real medicine.
If you think it is something more than bronchitis, go see your doctor, armed with the knowledge you've gained here. If it is bronchitis, and your doctor is following the science, what you need is a work note, time, and the plan. Take all three and trust the arc.
Related reading
Is It a Cold, Bronchitis, or Pneumonia? →
You don't need an antibiotic for bronchitis. You need a plan.
Bronchitis is a viral illness, not a bacterial infection. Antibiotics don't treat viruses or the symptoms they cause. If you believe you may have a bacterial infection, seek medical evaluation promptly.
Join the Movement
Your doctor should be getting this right. Now you'll know when they may not be.
Want to go deeper?
The clinician version isn't just for doctors. It's the same topic, written for physicians, the full reasoning, nothing simplified. You're allowed to read it. Read the clinician version →
HCP Guide — Peer to Peer · Russell W. Raskin, MD
Bronchitis: Cut the Crap
Fifty years of evidence. Your prescription pad hasn't read a word of it.
Russell W. Raskin, MD · Board-Certified Emergency Medicine & Internal Medicine · R.W. Raskin Health Protocols, LLC
You should have been taught this in medical school. You should be following the evidence. Yet nobody is watching you to see that you are doing this. I'm guessing you may be doing this wrong. Your prescription pad tells me it's so.
The evidence against antibiotics for acute bronchitis has been accumulating since 1976. Not 2001. Not 2017. 1976. Stott and West randomized patients with purulent cough to doxycycline versus placebo. No difference in cough duration. No difference in sputum. No difference in days missed from work. No difference in how sick patients felt.
That was fifty years ago.
The Evidence Timeline
Year
Study / Guideline
Finding
Verdict
1976
Stott & West RCT
Doxycycline vs. placebo, no difference across all outcomes
No benefit
1999
Meta-analysis, 8 RCTs
Antibiotics reduced cough by ~half a day, a "small benefit" the authors judged "not justified"
No benefit
2001
CDC / ACP / AAFP / IDSA
Routine antibiotics for uncomplicated acute bronchitis not recommended, regardless of cough duration
Against
2013
Little et al., Lancet Infect Dis, 2,061 patients, 12 countries
Amoxicillin: little symptomatic benefit over placebo [5]
No benefit
2017
Cochrane, 17 RCTs, 5,099 patients
Limited clinical benefit, increased adverse events, half a day difference at best
No benefit
2020
CHEST Expert Panel
Against routine prescription of any pharmacologic therapy for acute bronchitis
Any. At all.
The Therapeutic Cabinet Is Empty
Antibiotics
Evidence
Seventeen RCTs. 5,099 patients. Cochrane 2017. At best, half a day reduction in cough duration over an 8–10 day illness. Increased adverse events. ACP and CDC recommend against routine use. CHEST 2020 recommends against routine prescription of any pharmacologic therapy. [2,6,7]
Bronchodilators
Evidence
No benefit in patients without underlying asthma or COPD. The 2023 Llor et al. multiarm RCT (194 patients) randomized adults with uncomplicated acute bronchitis to dextromethorphan, ipratropium bromide, honey, or usual care. Median days with moderate-to-severe cough: 5–6 days in every single arm. Including usual care. Ipratropium did nothing. [11]
Corticosteroids
Evidence
The OSAC trial showed corticosteroids were not effective in adults without asthma presenting with acute lower respiratory tract infection. Not for cough duration. Not for symptom severity. Not routinely, for any outcome. [7]
Antitussives: Dextromethorphan, Codeine
Evidence
Codeine: no more effective than placebo in two trials. Dextromethorphan: no benefit in the most recent well-designed RCT (Llor 2023). Every arm performed identically. [11]
Benzonatate
Evidence + FDA Warning
FDA-approved since 1958. One placebo-controlled trial, negative. A 2025 prospective cohort of 718 patients: most commonly prescribed non-antibiotic for LRTI. Propensity score-matched analysis: no association with reduced cough duration, severity, or follow-up visits. [8]
FDA safety warning: Fatalities in children under 10 from accidental ingestion of as few as one or two capsules.
Narcotic Antitussives
Evidence + Safety
No RCT data specific to acute bronchitis. No evidence of benefit. The hydrocodone label warns against use in patients with productive cough, opioid suppression of the cough reflex may interfere with airway clearance. CHEST 2020 recommends against routine use of any antitussive class. [7]
NSAIDs / Mucolytics / Expectorants / Honey
Evidence
NSAIDs: ibuprofen vs. placebo, median 9 vs. 11 days. Not statistically significant. Mucolytics/expectorants/antihistamines: European Respiratory Society: do not prescribe in acute LRTI. Grade A1. [9] Honey: no benefit in adults. [11]
CHEST Expert Panel Report, 2020
"Insufficient evidence to confirm or refute the efficacy of prescribed treatments for cough due to acute bronchitis." — Smith MP et al. Chest. 2020;157(5):1256–1265.
That is the American College of Chest Physicians telling you the cabinet is empty. Every drawer. Every shelf. And yet, the overwhelming majority of patients still leave with a prescription of some sort. You know this because you are doing it. I know this because I did it too.
The One Exception That Proves the Rule
Clinically Defensible Carve-Out
The patient with known asthma or COPD is a different encounter. Bronchospastic disease changes the pathophysiology. Bronchodilators have a legitimate role during a virally-triggered exacerbation. Steroids may be appropriate. A lower threshold for antibiotics is warranted when bacterial superinfection is genuinely suspected in a compromised airway.
Know your patient. Treat the exacerbation, not the bronchitis.
This exception does not apply to the otherwise healthy adult with reactive bronchitis from RSV, rhinovirus, influenza, or any other viral URI without underlying pulmonary disease.
What You Cannot Do Is Not the Same As Nothing To Do
For those of us who do follow the science, here is where many of us fall short. We say "there's nothing I can give you" and we leave them adrift. The patient hears: you can't help me. They leave dissatisfied. They call back, or come back, with the same complaint in three days, or worse, they find someone who will prescribe.
Saying there is nothing to give is not the same as saying there is nothing to do. And conflating the two is where the prescription pad fills a void it was never supposed to fill.
There is a plan. And your job, your clinical value in that encounter, is to deliver it with the same authority you would give any other evidence-based intervention. Patient education and structured expectation-setting reduce antibiotic use, increase satisfaction, and improve outcomes. The plan works. You just have to give it. (Barrett B et al. Ann Fam Med. 2011;9(4):312–322.) [10]
Your patient needs three things from you in that encounter.
First, a diagnosis they can understand. Not "viral bronchitis." Not "it's going around." Tell them what is happening inside their airway. Their immune system is responding to a viral trigger. The bronchi are inflamed. The cough is the airway clearing itself. Discolored mucus is not a reliable sign of bacterial infection, it is a normal byproduct of immune engagement. Say that explicitly. It stops the "but it's discolored" argument before it starts.
Second, reframe the etiology argument before they make it. There is no practical test to distinguish viral from bacterial bronchitis in routine clinical practice, and it does not matter. Across 17 RCTs, antibiotics reduce cough duration by at most half a day regardless of cause. The etiology is irrelevant. The outcome data is not.
Third, name what they are feeling. Name it: Post-Traumatic Bronchitis Disorder, PTBD. Not a formal diagnosis. A clinical shorthand that tells your patient: I see what is happening here. You are not afraid of a cold. You are afraid of the memory of what bronchitis did to you. I understand. And I have a plan for you that works better, and more importantly, is safer.
What You Actually Prescribe
Set the Arc
Tell them the cough may last two to three weeks. Sometimes longer. Tell them the plateau is not escalation, it's their immune system doing what it's built to do in response to this kind of infection. Tell them what the recovery signal looks like: when the discolored mucus begins to clear, when the tickle in the chest begins to quiet, when exertion no longer paralyzes them with coughing. The patient who understands the arc does not call back on day five panicking.
Prescribe Absolute Rest
Not general rest. Absolute rest. Stop work. Talk less. Stop moving. Day one. This is the intervention most likely to change severity and duration. Write the work note. Without apology. Rest is the real prescription here. The work note is how you make it actionable.
Give Them the Four Pillars
Rest. Hydration and humidity. Stress management. Supplementation: I like zinc, quercetin, NAC, and vitamin C, each with individual evidence behind its mechanism, and I like to wash them down with green tea. Echinacea and elderberry are the two other supplements patients ask about most. The evidence for both is mixed, and the most rigorously designed trial for each tends to show the smallest or no effect, which is part of why I don't reach for them. [12,13,14,15]
Platform resource
Raskin's Four Pillars of Immune Optimization →
Tell Them When to Come Back
Return Precautions, Give Explicitly
Higher fever or fever that returns after resolution
True difficulty breathing, not just discomfort or chest tightness
Symptoms lasting beyond three weeks
Chest pain
Hemoptysis
New confusion or altered mental status
Anything that doesn't seem right, when in doubt, get checked out
The Close
You went into medicine to help patients get better. A prescription for bronchitis in the otherwise healthy, immunocompetent adult with structurally normal lungs does not do that. It exposes them to harm, contributes to resistance, and medicates a self-limiting condition that will resolve on its own, faster if they can rest, slower if they can't.
R.W. Raskinism
Stop using the prescription pad as a fast-forward button to skip the conversation. Start prescribing the plan.
Time and the immune system are the real medicine. The prescription pad was never the right tool. And now the plan has a home. Rest. Hydration. Stress management. Supplementation. Something tangible to hand a patient who feels like they need to walk out with more than words. The arc explained. The expectations set. The patient educated and sent home with a framework, a work note, and a plan designed to support their immune system through what it's built to do.
Related reading
URI, Bronchitis, and Pneumonia — The Clinical Spectrum →
For the exam room
The patient version is the plain-language take on the same topic — no jargon, no prescription pad. Built to hand a patient after the visit, so the conversation keeps going after they leave.
Gonzales R et al. Principles of Appropriate Antibiotic Use for Treatment of Uncomplicated Acute Bronchitis. Ann Emerg Med. 2001;37(6):720–727.
Smith SM et al. Antibiotics for Acute Bronchitis. Cochrane Database Syst Rev. 2017;6:CD000245.
Bent S et al. Antibiotics in Acute Bronchitis: A Meta-Analysis. Am J Med. 1999;107(1):62–67.
Smith SM et al. OTC Medications for Acute Cough. Cochrane Database Syst Rev. 2014;(11):CD001831.
Little P et al. Amoxicillin for Acute Lower-Respiratory-Tract Infection. Lancet Infect Dis. 2013;13(2):123–129.
Harris AM et al. Appropriate Antibiotic Use for Acute Respiratory Tract Infection. Ann Intern Med. 2016;164(6):425–434.
Smith MP et al. Acute Cough Due to Acute Bronchitis: CHEST Expert Panel Report. Chest. 2020;157(5):1256–1265.
Ebell MH et al. Corticosteroids, Antitussives, and Inhalers for Lower Respiratory Tract Infections. J Gen Intern Med. 2025. doi:10.1007/s11606-025-09733-x.
Woodhead M et al. Guidelines for the Management of Adult Lower Respiratory Tract Infections. Eur Respir J. 2005;26(6):1138–1180.
Barrett B et al. Treating the Common Cold. Ann Fam Med. 2011;9(4):312–322.
Llor C, Moragas A, Ouchi D, et al. Effectiveness of Antitussives, Anticholinergics, and Honey Versus Usual Care in Adults With Uncomplicated Acute Bronchitis: A Multiarm Randomized Clinical Trial. Fam Pract. 2023;40(2):407–413.
Wieland LS, Piechotta V, Feinberg T, et al. Elderberry for Prevention and Treatment of Viral Respiratory Illnesses: A Systematic Review. BMC Complement Med Ther. 2021;21(1):112.
Macknin M, Wolski K, Negrey J, Mace S. Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: A Randomized, Double-Blind, Placebo-Controlled Trial. J Gen Intern Med. 2020;35(11):3271–3277.
Karsch-Völk M, Barrett B, Kiefer D, et al. Echinacea for Preventing and Treating the Common Cold. Cochrane Database Syst Rev. 2014;(2):CD000530.
David S, Cunningham R. Echinacea for the Prevention and Treatment of Upper Respiratory Tract Infections: A Systematic Review and Meta-Analysis. Complement Ther Med. 2019;44:18–26.
You don't need to tell your patients there is nothing to do. There is something to do. It is evidence-based, it is effective, and it is yours to give.
